STAT3 and lung cancer: The release of inflammatory cytokines such as interferon-gamma (IFN-γ) activates the signal transducer and activator of transcription 3 (STAT3) pathway and subsequently upregulates PD-L1 expression on lymphoma and lung cancer cells [20].